Type 2 Diabetes Remission: An Overview
DOI:
https://doi.org/10.58931/cdet.2023.117Abstract
In my practice, one of the most common questions I encounter with my type 2 diabetes (T2D) patients is, “How can I get rid of this disease?” The primary focus of practitioners’ discussion regarding T2D is the chronicity and irreversibility of the condition. Recently, however, new hope is emerging concerning remission of diabetes with the increasing amount of evidence-based data available.
References
International Diabetes Federation. IDF diabetes atlas. 10th edition. Brussels: International Diabetes Federation. 2021. [accessed 2022 May 22]. https://www.diabetesatlas.org.
Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-1544. DOI: https://doi.org/10.1016/S0140-6736(16)31012-1
Spencer Bonilla G, Rodriguez-Gutierrez R, Montori VM. What we don’t talk about when we talk about preventing type 2 diabetes-addressing socioeconomic disadvantage. JAMA Intern Med 2016;176(8):1053-1054. DOI: https://doi.org/10.1001/jamainternmed.2016.2952
Canadian Diabetes Cost Model. Ottawa: Diabetes Canada; 2016.
MacKay D, Chan C, Dasgupta K, Dominy C, Gagner M, Jin S, et al. Diabetes Canada Clinical Practice Guidelines Steering Committee: Remission of Type 2 Diabetes: Diabetes Canada Clinical Practice Guidelines Expert Working Group. Can J Diabetes. 2022 Dec;46(8):753-761. DOI: https://doi.org/10.1016/j.jcjd.2022.10.009
UKPDS Group. U.K. Prospective Diabetes Study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 1995;44(11):1249-1258. DOI: https://doi.org/10.2337/diabetes.44.11.1249
Wysham C, Shubrook J. Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications. Postgrad Med 2020;132(8):676-686. DOI: https://doi.org/10.1080/00325481.2020.1771047
Albaugh VL, Axelrod C, Belmont KP, Kirwan JP. Physiology reconfigured: how does bariatric surgery lead to diabetes remission? Endocrinol Metab Clin North Am. 2023 Mar;52(1):49-64. DOI: https://doi.org/10.1016/j.ecl.2022.06.003
Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022 Dec;18(12):1345-1356. DOI: https://doi.org/10.1016/j.soard.2022.08.013
Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster randomised trial. Lancet Diabetes Endocrinol 2019;7(5):344e55. DOI: https://doi.org/10.1016/S2213-8587(19)30068-3
Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care. 2001 Sep;24(9):1522-1527. DOI: https://doi.org/10.2337/diacare.24.9.1522
Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, et al. Obesity in adults: a clinical practice guideline. CMAJ. 2020 Aug 4;192(31):E875-E891. DOI: https://doi.org/10.1503/cmaj.191707
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Canadian Diabetes & Endocrinology Today
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.